An enlarged prostate, medically called benign prostatic hyperplasia (BPH), is a non-cancerous increase in the size of the prostate gland that becomes increasingly common as men age. By the time men reach their fifties, roughly half already show microscopic evidence of it, and the condition is driven largely by the hormone dihydrotestosterone (DHT) acting on prostate tissue over decades. BPH is not prostate cancer and does not turn into cancer, but it can squeeze the urethra enough to cause frustrating urinary symptoms that range from mildly annoying to seriously disruptive.
Why the Prostate Keeps Growing
The prostate depends on androgens for its normal development and maintenance. Testosterone, produced mainly by the testes, gets converted inside prostate cells into DHT by an enzyme called 5-alpha reductase. DHT binds to receptors in the prostate and switches on genes that promote cell growth. During adolescence, this process builds the gland to its adult size. The problem is that the process never fully shuts off. In younger men, this hormonal signaling is beneficial, but in older men it drives ongoing, unwanted tissue expansion.1PubMed. The role of dihydrotestosterone in benign prostatic hyperplasia DHT is far more potent than testosterone at stimulating prostate growth, which is why drugs that block its production can slow or even reverse the enlargement.2The Journal of Clinical Endocrinology & Metabolism. Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor
Data from longitudinal aging studies suggest the prostate grows at a rate of about 2% to 2.5% per year in older men. That does not sound like much, but compounded over decades it adds up. A prostate that weighs 20 grams at age 30 can easily double or triple in size by 70. Because the prostate wraps around the urethra like a doughnut, even moderate enlargement can start to pinch the urinary channel and create symptoms.3PubMed Central. Epidemiology of clinical benign prostatic hyperplasia
How Common Is It
BPH is one of the most prevalent conditions in older men worldwide. Autopsy studies, which catch BPH regardless of whether it ever caused symptoms, show a histological prevalence of about 8% in men in their thirties, 50% in men in their fifties, and 80% by the time men reach their eighties.3PubMed Central. Epidemiology of clinical benign prostatic hyperplasia Not every man with microscopic BPH develops bothersome symptoms, but a substantial portion does. Globally, the number of prevalent BPH cases has been rising across all age groups, driven by population aging. The highest concentration of cases sits in the 65-to-69 age bracket.4Scientific Reports. Comprehensive analysis of the global, regional, and national burden of benign prostatic hyperplasia from 1990 to 2021
Age is the single strongest risk factor, but it is not the only one. Family history plays a role, and certain metabolic conditions can accelerate prostate growth, a topic covered further below.
Recognizing the Symptoms
The symptoms of BPH fall into two broad groups. Voiding symptoms are caused by the enlarged gland physically blocking urine flow: a weak or intermittent stream, straining to start urination, a sense of incomplete emptying, and dribbling at the end. Storage symptoms are caused by the bladder itself becoming irritable from constantly working against the obstruction: frequent urination (especially at night), urgency, and sometimes urge incontinence. Many men experience a mix of both.
Interestingly, storage symptoms appear to be worsened by metabolic syndrome. A study of men with prostate enlargement found that those who also had metabolic syndrome scored significantly higher on measures of storage-type complaints like urgency and frequency, with roughly 1.8 times the odds of elevated storage symptom scores compared to men without metabolic syndrome.5PubMed Central. Metabolic syndrome and benign prostatic hyperplasia: An update This means that the severity of BPH symptoms is not determined by prostate size alone. Two men with identically sized prostates can have very different symptom profiles depending on their overall metabolic health.
How BPH Is Diagnosed
If you visit a doctor with urinary complaints suggestive of BPH, the workup is usually straightforward. Most clinicians start with a standardized symptom questionnaire called the International Prostate Symptom Score (IPSS), which asks you to rate how often you experience seven specific urinary symptoms. The score helps classify symptoms as mild, moderate, or severe and gives doctors a baseline to track whether treatment is working.
A digital rectal exam (DRE) lets the doctor feel the prostate’s size, shape, and consistency through the rectal wall. It remains a useful and accessible first-line tool, particularly in settings where advanced imaging is not readily available.6PubMed Central. Evaluating prostate cancer diagnostic methods: The role and relevance of digital rectal examination in modern era A blood test for prostate-specific antigen (PSA) is often drawn at the same time. PSA is produced by prostate cells, so it rises with prostate size, but it also rises with prostate cancer and with inflammation, making it an imperfect tool for distinguishing one condition from another. Additional tests like urine flow rate measurements and ultrasound of the bladder after voiding can help gauge how much the obstruction is affecting function.
BPH and Prostate Cancer Are Not the Same Thing
This is the reassurance most men want first: BPH is not cancer and having BPH does not mean you will get cancer. However, the two conditions share enough overlap to cause real confusion. Both become more common with age according to autopsy data, though cancer lags behind BPH by about 15 to 20 years. Both are influenced by androgens, and both can elevate PSA levels. Most prostate cancers are actually found in glands that also have BPH present, simply because BPH is so common.7Cancer. The association of benign prostatic hyperplasia and cancer of the prostate
The coexistence of BPH and cancer in the same gland is one reason PSA testing gets complicated. A very large prostate with BPH can push PSA levels into ranges that trigger concern about cancer. One way to improve diagnostic accuracy is the free-to-total PSA ratio, which tends to be lower in men with cancer. But a study found that this ratio only reliably distinguished BPH from cancer in men with prostate volumes under 40 cubic centimeters. Above that threshold, the two groups looked statistically similar on this measure.8Cancer. The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia The practical message is that ruling out cancer in men with large prostates often requires additional steps like MRI or biopsy rather than relying on blood tests alone.
Medication Options
When BPH symptoms are moderate enough to bother you but not severe enough to require surgery, medications are the standard first step. The two main drug classes work in completely different ways.
Alpha blockers (tamsulosin, alfuzosin, silodosin, and others) relax the smooth muscle in the prostate and bladder neck. This reduces the physical squeeze on the urethra and improves urine flow, often within days to weeks.9PubMed. Alpha blockers: are all created equal? They do not shrink the prostate. They work well for symptom relief but do not slow the progression of the disease. Side effects can include dizziness, nasal congestion, and retrograde ejaculation.
5-alpha reductase inhibitors (finasteride and dutasteride) take the opposite approach. They block the conversion of testosterone to DHT, which actually shrinks the prostate over time. One study showed that finasteride reduced prostate volume by about 27% from baseline over 36 months and improved urinary flow rate alongside symptom scores. Men with the largest prostates tended to benefit the most.10PubMed Central. 5-alpha reductase inhibitors use in prostatic disease and beyond The tradeoff is time: these drugs take several months to produce noticeable effects. They also lower PSA levels, which means your doctor needs to account for that adjustment if you are being monitored for prostate cancer.11PubMed Central. The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia For men with large prostates and significant symptoms, combination therapy using both drug classes is common.
When Surgery or Procedures Become an Option
If medications are not enough, or if complications develop, procedural options range from traditional surgery to newer minimally invasive approaches. The longstanding gold standard is transurethral resection of the prostate (TURP), which removes obstructing prostate tissue through the urethra with no external incision. In network meta-analyses ranking interventions by re-intervention rates, TURP consistently ranks at or near the top, meaning fewer men need a repeat procedure afterward.12PubMed. Systematic review and network meta-analysis of re-intervention rates of new surgical interventions for benign prostatic hyperplasia
Newer alternatives aim to offer similar relief with shorter recovery times or fewer sexual side effects. Aquablation uses a robotic waterjet to remove tissue and has shown urinary outcomes comparable to TURP in clinical trials. UroLift deploys small implants that hold prostate lobes apart, opening the urethra without removing tissue. Rezum uses steam injections to destroy excess prostate cells. Compared to TURP and Aquablation, UroLift and Rezum produce somewhat less dramatic improvements in urine flow and symptom scores, but UroLift in particular has shown better preservation of sexual function.13PubMed. An Indirect Comparison of Newer Minimally Invasive Treatments for Benign Prostatic Hyperplasia: A Network Meta-Analysis Model The choice often comes down to prostate size, the man’s priorities around sexual function, and how much symptom relief is needed.
Prostate artery embolization (PAE) is a newer option performed by an interventional radiologist rather than a urologist. Tiny particles are injected into the arteries feeding the prostate, cutting off blood supply and causing the gland to shrink. Clinical trials show consistent improvement in symptoms and quality of life with low complication rates, although outcomes on urinary flow and symptom scores tend to be somewhat less robust than with TURP.14PubMed Central. The State of Evidence in Prostate Artery Embolization PAE may be a good fit for men who want to avoid surgery entirely or who have health conditions that make anesthesia risky.
How Metabolic Health Feeds Into Prostate Growth
Age and hormones get most of the attention in BPH discussions, but metabolic factors deserve a mention because they are modifiable. Metabolic syndrome, the cluster of conditions including central obesity, insulin resistance, high blood pressure, and abnormal cholesterol, has been linked to both the development and progression of BPH and related urinary symptoms across multiple studies.15PubMed Central. Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome The proposed mechanisms involve insulin resistance promoting prostate cell growth, increased inflammatory activity inside the gland, and shifts in sex hormone balance that come with visceral fat accumulation.16PubMed Central. Metabolic Syndrome and Benign Prostatic Hyperplasia: Evidence of a Potential Relationship, Hypothesized Etiology, and Prevention
The practical takeaway is that maintaining a healthy weight, staying physically active, and managing blood sugar and cholesterol are not just good for your heart. They may also slow prostate growth and reduce the severity of urinary symptoms. This does not mean that fit men never get BPH, but it does suggest that lifestyle factors can shift the odds and the timeline.
Saw Palmetto and Herbal Supplements
Saw palmetto extract is probably the most widely used herbal supplement for BPH, and its story is a good illustration of how supplement evidence can be muddy. The extract, derived from the berries of the Serenoa repens palm, is thought to interfere with DHT production in the prostate, which is the same basic mechanism as the prescription 5-alpha reductase inhibitors. Early studies, many of them small and uncontrolled, looked promising.
The most rigorous test came from a randomized, placebo-controlled trial published in JAMA that escalated saw palmetto doses over 72 weeks. Symptom scores improved in both the saw palmetto and placebo groups, but the placebo group actually improved slightly more. Saw palmetto was no better than placebo for any outcome measured.17JAMA. Effect of Increasing Doses of Saw Palmetto Extract on Lower Urinary Tract Symptoms: A Randomized Trial However, part of the inconsistency in the broader literature may stem from a lack of standardized formulations. One review noted that a hexane-based extract with a high free fatty acid content gave more consistent results than other preparations.18PubMed Central. Use of saw palmetto (Serenoa repens) extract for benign prostatic hyperplasia A separate small trial found that a beta-sitosterol-enriched saw palmetto formulation did outperform placebo on symptom scores, urine flow, and residual volume.19PubMed Central. A double blind, placebo-controlled randomized comparative study on the efficacy of phytosterol-enriched and conventional saw palmetto oil in mitigating benign prostate hyperplasia and androgen deficiency The honest summary is that most high-quality evidence does not support generic saw palmetto for BPH symptoms, though specific extract formulations may eventually prove to be exceptions. If you want to try it, do not use it as a substitute for proven treatments, especially if your symptoms are worsening.
What Happens to the Bladder Over Time
One reason urologists encourage treatment rather than just tolerating symptoms is what BPH does to the bladder if the obstruction goes unchecked for years. When the bladder has to push against a narrowed outlet repeatedly, the muscle wall thickens and remodels. The smooth muscle cells in the bladder wall enlarge, and the tissue between them accumulates excess collagen and elastic fibers.20PubMed Central. Progressive bladder remodeling due to bladder outlet obstruction: a systematic review of morphological and molecular evidences in humans Initially, this thickening helps the bladder maintain its ability to empty. Over time, though, the remodeling can become counterproductive, leading to a stiff, poorly contractile bladder that cannot empty fully even after the obstruction is relieved.
If BPH progresses far enough without treatment, complications can include acute urinary retention (a sudden inability to urinate, which is a medical emergency), chronic urinary retention, bladder stones, recurrent urinary tract infections, and in severe cases, kidney damage from back-pressure.21PubMed Central. Management of the complications of BPH/BOO The historical concern about BPH was actually renal failure, though modern treatment has shifted the focus toward improving quality of life long before the kidneys are at risk.22PubMed. Early treatment of benign prostatic hyperplasia: implications for reducing the risk of permanent bladder damage
Sexual Function and BPH
BPH and sexual problems are entwined in ways that many men do not expect. Lower urinary tract symptoms themselves are associated with erectile dysfunction, independent of any treatment effect. The relationship likely involves shared pathways including reduced blood flow, nerve signaling changes, and the psychological burden of dealing with persistent urinary issues. On top of that, some BPH treatments add their own sexual side effects. 5-alpha reductase inhibitors can reduce libido and occasionally cause erectile problems, while surgical procedures, particularly TURP, frequently cause retrograde ejaculation (where semen goes into the bladder during orgasm rather than out). High-quality evidence confirms that BPH-related symptoms and certain treatments are significant predictors of erectile dysfunction.23Sexual Medicine Reviews. Lower urinary tract symptoms and male sexual function: recommendations from the fifth international consultation on sexual medicine (ICSM 2024)
Not all surgical options carry the same risks. A prospective study of holmium laser enucleation of the prostate (HoLEP) found that overall sexual function, including erection and desire, did not change significantly after the procedure. Retrograde ejaculation did occur in about 63% of patients, and satisfaction scores dipped slightly because of it. However, sexual satisfaction actually improved in proportion to how much urinary symptoms improved, suggesting that the relief from bothersome urinary problems outweighed the ejaculatory change for many men.24PubMed Central. HoLEP does not affect the overall sexual function of BPH patients: a prospective study
Self-Management Strategies That Actually Help
Before reaching for medications, or alongside them, behavioral changes can make a real difference for men with mild to moderate symptoms. Research suggests that structured self-management programs can reduce urinary symptoms as effectively as medication in some men and reduce the likelihood of needing to escalate to more aggressive treatments.25PubMed. Self-management for men with lower urinary tract symptoms Practical strategies include:
- Fluid timing: reducing fluid intake in the evening, particularly caffeine and alcohol, to cut down on nighttime trips to the bathroom.
- Double voiding: waiting a moment after finishing urination and then trying again, which helps empty the bladder more completely.
- Bladder training: gradually extending the intervals between bathroom visits to retrain the bladder’s capacity and reduce urgency.
- Pelvic floor exercises: trials have shown that pelvic floor muscle training can reduce post-void dribbling, with one study reporting that three-quarters of men in the exercise group had no dribbling at six months compared to no improvement in the counseling-only group.26Andrology-Open Access. Behavioral Interventions for Managing Lower Urinary Tract Symptoms in Men: A Literature Review from 2018 to 2024
These approaches work best when symptoms are still in the mild-to-moderate range. They are not a substitute for medical treatment in men with significant obstruction or complications, but they can meaningfully improve comfort and delay the need for prescription drugs.
Dogs, Prostates, and Why Researchers Study Both
Humans are not the only species that develops BPH. Dogs are the only other animal known to develop it spontaneously as they age, which has made the canine prostate a valuable research model. In beagles, the condition first appears as a glandular overgrowth early in life and then progresses to a more complex mixture of glandular, cystic, and stromal tissue with age, mirroring the pathological stages seen in men.27Urologic Clinics of North America. Clinical and Experimental Studies of Benign Prostatic Hyperplasia Researchers can even induce BPH in young dogs by treating them with DHT, and the resulting tissue changes are identical to what happens naturally in aging dogs, further confirming the central role of DHT.28JCI Insight. Comparison of spontaneous and experimentally induced canine prostatic hyperplasia
There is one key anatomical difference. In dogs, the prostate enlarges symmetrically outward, away from the urethra, so canine BPH tends to cause fewer urinary obstruction problems than human BPH does.29PubMed Central. A retrospective review of canine benign prostatic hyperplasia with and without prostatitis In men, the growth tends to compress inward toward the urethral channel. That anatomical quirk is a major reason why a relatively modest amount of prostate enlargement can produce such outsized urinary symptoms in humans. It also explains why neutering dogs, which eliminates the testosterone that feeds DHT production, reliably resolves canine BPH. In men, the hormonal picture is more complicated and removing testosterone entirely is not a practical or desirable treatment strategy, which is why the more targeted approach of blocking DHT with 5-alpha reductase inhibitors emerged instead.